We report a case of recurrent post-traumatic ulcer infection due to Myroides odoratimimus in an immunocompromised male. We have also reviewed the medical literature on isolated M. odoratimimus infections. The strain, isolated from ulcer discharge, was multidrug resistant and treatment with meropenem, based on susceptibility testing, led to resolution of infection. The strain was also able to form a relevant amount of biofilm over time, thus suggesting a possible role of sessile communities in the chronicization of infection. To our knowledge, this is the first description of recurrent ulcer infection caused by a biofilm-producer M. odoratimimus strain. This case reminds us of the need to consider uncommon pathogens as etiology of skin and soft tissue infections, especially in immunocompromised patients. Further, since the treatment of infections due to M. odoratimimus is often difficult both due to multidrug resistance and scarce clinical experience, antibiotic therapy should be adapted to in vitro susceptibility testing
Infection of recurrent calcanear ulcer aused by a biofilm-producer Myroides odoratimimus strain
Gherardi G;
2018-01-01
Abstract
We report a case of recurrent post-traumatic ulcer infection due to Myroides odoratimimus in an immunocompromised male. We have also reviewed the medical literature on isolated M. odoratimimus infections. The strain, isolated from ulcer discharge, was multidrug resistant and treatment with meropenem, based on susceptibility testing, led to resolution of infection. The strain was also able to form a relevant amount of biofilm over time, thus suggesting a possible role of sessile communities in the chronicization of infection. To our knowledge, this is the first description of recurrent ulcer infection caused by a biofilm-producer M. odoratimimus strain. This case reminds us of the need to consider uncommon pathogens as etiology of skin and soft tissue infections, especially in immunocompromised patients. Further, since the treatment of infections due to M. odoratimimus is often difficult both due to multidrug resistance and scarce clinical experience, antibiotic therapy should be adapted to in vitro susceptibility testingI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.